The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation
Open accessAbstract
This article presents the conclusions of a WHO Expert Consultation that evaluated the utility of the ‘metabolic syndrome’ concept in relation to four key areas: pathophysiology, epidemiology, clinical work and public health. The metabolic syndrome is a concept that focuses attention on complex multifactorial health problems. While it may be considered useful as an educational concept, it has limited practical utility as a diagnostic or management tool. Further efforts to redefine it are inappropriate in the light of current knowledge and understanding, and there is limited utility in epidemiological studies in which different definitions of the metabolic syndrome are compared. Metabolic syndrome is a pre-morbid condition rather than a clinical diagnosis, and should thus exclude individuals with established diabetes or known cardiovascular disease (CVD). Future research should focus on: (1) further elucidation of common metabolic pathways underlying the development of diabetes and CVD, including those clustering within the metabolic syndrome; (2) early-life determinants of metabolic risk; (3) developing and evaluating context-specific strategies for identifying and reducing CVD and diabetes risk, based on available resources; and (4) developing and evaluating population-based prevention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Self-citationRole of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Self-citationTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Effective lifestyle and pharmaceutical approaches to the prevention of diabetes and CVD in high-risk individuals are well established [32–35].”
BackgroundSelf-citationThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Self-citationEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Self-citationGrundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Self-citationComment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 1×
“Subsequently, a number of different definitions have been developed for this purpose by the WHO [4], the National Cholesterol Education Program Adult Treatment Panel III (ATP III) [5], the European Group for the Study of Insulin Resistance [6] and, most recently, the International Diabetes Federation (IDF) [7].”
MethodFord, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710
Millennium Development Goals Report
(2016) · Millennium development goals report · doi:10.18356/98544aa9-en · Cited by 1,683
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Carr, D. B., Utzschneider, K. M., Hull, R. L., Kodama, K., Retzlaff, B. M., Brunzell, J. D., Shofer, J. B., Fish, B. E., Knopp, R. H., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2087 · Cited by 993
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Sleep apnea is a manifestation of the metabolic syndrome
Vgontzas, A. N., Bixler, E. O., & Chrousos, G. P. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2005.01.006 · Cited by 559
Eyre, H., Kahn, R., Robertson, R. M., the ACS/ADA/AHA Collaborative Writing Committee, ACS/ADA/AHA Collaborative Writing Committee Members, Clark, N. G., Doyle, C., Hong, Y., Gansler, T., Glynn, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000133321.00456.00 · Cited by 542
The metabolic syndrome: is this diagnosis necessary?1,2
Reaven, G. M. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1237 · Cited by 524
Self-citationSattar, N., McConnachie, A., Shaper, A. G., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., Jukema, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60602-9 · Cited by 493
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1876-2 · Cited by 376
Mendis, S., Lindholm, L. H., Mancia, G., Whitworth, J., Alderman, M., Lim, S., & Heagerty, T. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282861fd3 · Cited by 332
Self-citationEyre, H., Kahn, R., Robertson, R. M., and the ACS/ADA/AHA Collaborative Writing Committee, Clark, N. G., Doyle, C., Gansler, T., Glynn, T., Hong, Y., Smith, R. A., et al. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.4.190 · Cited by 329
Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome
Fernandez-Twinn, D. S., & Ozanne, S. E. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.05.039 · Cited by 304
Mancia, G., Bombelli, M., Corrao, G., Facchetti, R., Madotto, F., Giannattasio, C., Trevano, F. Q., Grassi, G., Zanchetti, A., & Sega, R. (2007) · Hypertension · doi:10.1161/01.hyp.0000251933.22091.24 · Cited by 252
Metabolic syndrome and cancer risk
Russo, A., Autelitano, M., & Bisanti, L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.11.005 · Cited by 224
High Prevalence of the Metabolic Syndrome in Iranian Adolescents
Esmaillzadeh, A., Mirmiran, P., Azadbakht, L., Etemadi, A., & Azizi, F. (2006) · Obesity · doi:10.1038/oby.2006.50 · Cited by 201
Distribution of body fat and risk of coronary heart disease in men and women
Canoy, D. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328313133a · Cited by 171
Kohro, T., Furui, Y., Mitsutake, N., Fujii, R., Morita, H., Oku, S., Ohe, K., & Nagai, R. (2008) · International Heart Journal · doi:10.1536/ihj.49.193 · Cited by 160
Selection of measures in epidemiologic studies of the consequences of obesity
Stevens, J., McClain, J. E., & Truesdale, K. P. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.88 · Cited by 115
The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study
Cameron, A. J., Magliano, D. J., Zimmet, P., Welborn, T. A., Colagiuri, S., Tonkin, A. M., & Shaw, J. E. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01935.x · Cited by 108
Self-citationThe search for putative unifying genetic factors for components of the metabolic syndrome
Sjögren, M., Lyssenko, V., Jonsson, A. E., Berglund, G., Nilsson, P. M., Groop, P., & Orho‐Melander, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1151-4 · Cited by 79
Wild, S. H., & Byrne, C. D. (2005) · Wiley eBooks · doi:10.1002/0470025131.ch1 · Cited by 70
The metabolic syndrome and cardiovascular risk: implications for clinical practice
Eddy, D. M., Schlessinger, L., & Heikes, K. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.28 · Cited by 54
Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
Kohli, P., & Greenland, P. (2006) · JAMA · doi:10.1001/jama.295.7.819 · Cited by 48
Lee, C., Huxley, R., Woodward, M., Zimmet, P., Shaw, J. E., Cho, N. H., Kim, H. R., Viali, S., Tominaga, M., Vistisen, D., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.05.011 · Cited by 31
Self-citation
Cited by
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Yki-Järvinen, H. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70032-4 · Cited by 1,259
Risk factors for periodontal disease
Genco, R. J., & Borgnakke, W. S. (2013) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00457.x · Cited by 1,232
Samson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Flax and flaxseed oil: an ancient medicine & modern functional food
Goyal, A., Sharma, V., Upadhyay, N., Gill, S., & Sihag, M. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-013-1247-9 · Cited by 742
Guo, S. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 623
Metadata
- Authors
- Simmons, R. K., Alberti, K. G. M. M., Gale, E. A. M., Colagiuri, S., Tuomilehto, J., Qiao, Q., Ramachandran, A., Tajima, N., Brajkovich Mirchov, I., Ben-Nakhi, A., Reaven, G., Hama Sambo, B., Mendis, S., & Roglic, G.
- Venue
- Diabetologia
- Published
- 2009-12-11
- Volume
- 53
- Issue
- 4
- Pages
- 600-605
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2019734687
- Cited by
- 456
- References
- 37
- FWCI
- 25.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.